
Troy Cox
Director · MapLight Therapeutics, Inc.
- 2024
- Jul 29, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Troy Cox files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Catalyst4, Inc. - $191.21M in MPLT purchases and sales in the last 12 months
- Novo Holdings A/S - $16.20M in MPLT purchases and sales in the last 12 months
- Christopher A. Kroeger - $12.54M in MPLT purchases and sales in the last 12 months
- Jonathan Gillis - $3.56M in MPLT purchases and sales in the last 12 months
- Erin Pennock Foff - $3.38M in MPLT purchases and sales in the last 12 months
- Anatol Kreitzer - $2.78M in MPLT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Troy Cox?
Troy Cox is a corporate insider, tracked as Director of MapLight Therapeutics, Inc. (MPLT). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Troy Cox submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Troy Cox been buying or selling stock?
Recorded transactions: 1 open-market purchase ($149K) and 0 open-market sales across all tracked filings.